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C L I N I C A L R E S E A R C H A R T I C L E
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Context: The endocrine function of human fetal adrenals (HFAs) is activated already during first
trimester, but adrenal steroidogenesis during fetal life is not well characterized.
Objective: This study aimed to investigate HFA steroidogenesis by analyzing adrenal glands from
first and second trimesters.
Design and Setting: Male and female HFA from gestational weeks (GWs) 8 to 19 were examined,
including a total of 101 samples from 83 fetuses.
Main Outcome Measure(s): Expression level of steroidogenic genes and protein expression/
localization were determined by quantitative PCR and immunohistochemistry, respectively, and
intra-adrenal steroid levels were quantified by LC-MS/MS.
Results: Transcriptional levels of StAR, CYP11A1, CYP17A1, CYP21A2, CYP11B1/2, and SULT2A1
were significantly higher in second trimester compared to first trimester (P , 0.05), whereas ex-
pression levels of 3b-HSD2 and ARK1C3 were unaltered between GWs 8 and 19. All investigated
steroidogenic proteins were expressed in a distinct pattern throughout the investigated period,
with most enzymes expressed primarily in the fetal zone, except 3b-HSD1/2, which was expressed
mainly in the definitive zone. Abundant steroidogenic enzyme expression was reflected in overall
high intra-adrenal tissue concentrations of mineralocorticoids, glucocorticoids, and androgens;
cortisol was the most abundant (1071 to 2723 ng/g tissue), and testosterone levels were the lowest
(2 to 14 ng/g tissue).
Conclusions: The expression profiles of HFA steroidogenic enzymes are distinct from first to second
trimester, with no major differences between male and female samples. Intra-adrenal steroid
hormone concentrations confirm that cortisol is produced throughout first and second trimesters,
suggesting continued regulation of the hypothalamus-pituitary-adrenal axis during this entire
period. (J Clin Endocrinol Metab 104: 1802–1812, 2019)
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Abbreviations: 3b-HSD2, 3b-hydroxysteroid dehydrogenase type 2; ARK1C3, aldo-keto
reductase family 1 member C3; CAH, congenital adrenal hyperplasia; CYP11A1, Cyto-
chrome P450 11A1; CYP11B1/2, Cytochrome P450 11B; CYP17A1, Cytochrome P450
17A1; CYP21A2, Cytochrome P450 21A2; DZ, definitive zone; FZ, fetal zone; GW,
gestational week; HFA, human fetal adrenal; HPA, hypothalamus-pituitary-adrenal; IHC,
immunohistochemistry; MC2R, melanocortin 2 receptor; RT-PCR, real-time polymerase
chain reaction; StAR, Steroidogenic acute regulatory protein; SULT2A1, Sulfotransferase
Family 2A Member 1; TZ, translational zone.
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The morphology of the human fetal adrenal (HFA)gland differs from that of the adult organ. Thus, the
morphology of the HFA gland is established around
gestational week (GW) 7, where the adrenal cortex has
differentiated from adrenogenital primordial cells into a
distinct morphology consisting of two separate zones, a
thin outer definitive zone (DZ) and an inner fetal zone
(FZ) that accounts for 80% to 90% of the adrenal tissue
(1). During the second trimester, an additional transi-
tional zone (TZ) develops at the interface between the DZ
and FZ, after which the morphology of the HFA gland is
unchanged until birth (1).
Activation of the hypothalamus-pituitary-adrenal
(HPA) hormone axis is essential for adrenal steroido-
genic enzyme expression (2). Thus, activation of the
adrenal melanocortin receptor 2 (MC2R) through
binding of pituitary-secreted ACTH is necessary for the
endocrine capacity of the HFA gland (1, 3, 4). The FZ
(and later the TZ) is described as the most steroidogenic
active zone, expressing Steroidogenic acute regulatory
protein (StAR), cytochrome P450 11A1 (CYP11A1),
cytochrome P450 17A1 (CYP17A1), cytochrome P450
21A2 (CYP21A2), cytochrome P450 11B (CYP11B1/
CYP11B2), and Sulfotransferase Family 2A Member 1
(SULT2A1) from around GW 7 (4–6). Throughout
gestation, CYP17A1 and SULT2A1 are exclusively lo-
calized to the FZ and TZ (1, 7–9), whereas CYP11A1,
CYP21A2, and StAR are also expressed in the DZ from
around GW 23 (7, 8, 10, 11).
3b-hydroxysteroid dehydrogenase type 2 (3b-HSD2)
mediates the adrenal de novo synthesis of D4 steroid
hormones. Because the adrenal expression of 3b-HSD1 is
very low compared with that of 3b-HSD2 (4, 12), the
detection of 3b-HSD1/2 in this study is thought to
represent mainly expression of 3b-HSD2. In contrast
to the other HFA steroidogenic enzymes, 3b-HSD2 is
expressedmainly in DZ cells fromGWs 7 to 10 (3, 4, 7, 8,
11). However, a recent study showed a continued 3b-
HSD2 expression throughout the second trimester (13).
This finding suggests that in addition to its role in the
regulation of fetal adrenal cortisol-mediated negative
feedback on the HPA axis to minimize adrenal androgen
synthesis during the critical time window of sex differ-
entiation (4, 14–16), the 3b-HSD2 enzyme also may act
as a negative regulator throughout the second trimester.
HFA steroidogenesis is tightly regulated throughout the
first and second trimesters, which is crucial because the
adrenal steroid hormones affect the overall intrauterine
endocrine environment from early fetal development. El-
evated levels of HFA androgens can be a consequence of
dysregulated adrenal steroid pathways, in which imbal-
anced steroidogenesis can cause masculinization of the
external genitals in female fetuses with congenital adrenal
hyperplasia (CAH) (17). However, HFA steroidogenesis is
not well characterized during fetal development, as pre-
vious studies investigating the steroidogenic function have
focused on either the first or the second/third trimester
only, characterizing selected adrenal steroidogenic en-
zymes. This study therefore aimed to collect detailed ex-
pression data of all the classic steroidogenic enzymes and
determine the intra-adrenal steroid levels from the first-
and second-trimester HFAs in one inclusive study. Thus,
this study examined both HFA tissue steroid levels and
gene and protein expression of steroidogenic enzymes
throughout first- and second-trimester fetal development.
Material and Methods
Collection of human fetal adrenals and
ethical approvals
HFA tissue from the first trimester (GWs 8 to 12) and second
trimester (GWs 14 to 19) were isolated from material avail-
able following elective surgical termination of pregnancy at
Copenhagen University Hospital (Rigshospitalet) andHvidovre
Hospital, Denmark, as well as the Royal Infirmary of Edin-
burgh, United Kingdom, and the Human Developmental Bi-
ology Resource, United Kingdom. A total of 101 HFA samples
collected from 83 individual fetuses were used in this study, as
two adrenals from the same fetus were occasionally used in
different analyses. The study was approved by the Danish re-
gional ethics committee (H-1-2012-007) and the UK Lothian
Research Ethics committee (LREC08/S1101/1). Woman gave
their informed written and oral consent. None of the termi-
nations were for reasons of fetal abnormality, and all fetuses
appeared morphologically normal. Fetal age was determined
by scanning crown-rump length and confirmed by evaluation
of foot length (18). Hence, fetal age is about 2 weeks greater
than in studies reporting days/weeks after conception. After
dissection, adrenal tissue samples were either snap frozen
at 280°C or fixed immediately in 4% buffered formalin. Fetal
sex determination was based on PCR using specific primers
targeting SRY (Table 1). DNA for sex determination was
extracted from fetal limb tissue and isolated with NucleoSpin
Genomic DNA as described by the manufacturer (Macherey-
Nagel, Du¨ren, Germany). PCR cycle conditions were as follows:
one cycle of 3 minutes at 95°C, 25 cycles of 30 seconds at 95°C,
1 minute at 60°C, 1.5 minutes at 65°C, and one cycle of
5 minutes at 72°C.
Gene expression
Total RNA was extracted from one frozen HFA gland in
samples from GWs 8 to 12 (11 male and 11 female, collected
from 22 fetuses), whereas half of a frozen HFA glandwas used in
samples fromGWs 14 to 19 (9 male and 8 female, collected from
17 fetuses) and isolated using theNucleoSpinRNA II purification
kit according to the manufacturer’s instructions (Macherey-
Nagel, Du¨ren, Germany). cDNA was synthesized using a
dT20 primer and random hexamers. Real-time polymerase chain
reaction (RT-PCR) was performed using specific primers tar-
geting preselected mRNAs. All primers were designed to span
intron-exon boundaries with optimal annealing temperatures of
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;62°C, comparable primer length, and CG contents (Table 1). All
amplicons were initially verified by sequencing (Eurofins MWG
GmbH, Ebersberg, Germany), and primer amplification efficiency
and detectable dynamic range of all primer sets were validated
before the analysis of the HFA samples. RT-PCR cycle conditions
were as follows: one cycle of 3 minutes at 95°C, 40 cycles of
30 seconds at 95°C, 1 minute at 62°C, 1 minute at 72°C, and one
cycle of 5 minutes at 72°C. Quantitative RT-PCR analysis was
performed in triplicate using Brilliant II SYBRGreen qPCRMaster
Mix (Agilent Technologies, Santa Clara, CA). Changes in gene
expression were quantified using the 22DDCt method (19). Ex-
pression levels were normalized to the reference gene, RPS20, and
calculated as a ratio with male samples GWs 8 to 9 set to 1 in
respective samples.
Immunohistochemistry
Adrenal tissue from GWs 8 to 12 (13 male and 13 female,
collected from 26 fetuses) and GWs 14 to 19 (10 male and 6
female, collected from 16 fetuses) were used for immunohis-
tochemistry (IHC). Formalin-fixed adrenal tissues were dehy-
drated, paraffin embedded, and sectioned (4 mm) using
standard procedures. Primary antibodies, dilutions, and re-
trieval buffers are listed in Table 2. IHC staining was initially
conducted according to a standard protocol as described pre-
viously (20). Subsequently, the protocol was modified to in-
clude antigen retrieval by pressure cooker as previous described
(21). In brief, tissue sections were subjected to heat-induced
antigen retrieval buffer in a pressure cooker, and endogenous
peroxidase was blocked with 3% (v/v) H2O2 in MeOH for
30 minutes. Between each step, sections were washed in Tris-
buffered saline. Sections were incubated in 5% BSA (w/v) in
horse serum (20% v/v) ImmPRESS (Vector Laboratories,
Burlingame, CA) and Tris-buffered saline (80% v/v) or 0.5%
milk powder for 30minutes depending on optimization for each
antibody. Sections were subsequently incubated overnight with
primary antibody diluted in serum at 4°C in a humidified
chamber followed by 1 hour at room temperature. Sections
were then incubated for 30 minutes with the appropriate
ImmPRESS HRP (peroxidase, Vector Laboratories) secondary
antibody diluted in normal serum. Visualization was performed
using ImmPACT AEC peroxidase substrate (Vector Labora-
tories, Burlingame, CA). Included negative controls replaced the
primary antibody with dilution buffer only, none of which
showed any staining. All sections were counterstained with
Mayer hematoxylin before mounting with Aquatex (Merck,
Damstadt, Germany).
Quantification of stained cells
Two independent investigators evaluated all stainings. Sec-
tions were first investigated manually on a Nikon Microphot-
FXA microscope; subsequently, slides were scanned on a
NanoZoomer 2.0 HT (Hamamatsu Photonics, Herrsching am
Ammersee, Germany) and analyzed using NDP view software,
version 1.2.36 (Hamamatsu Photonics). The intensity of im-
munoreactivity was classified according to a predefined scoring
system: ++, strong staining in all cells of a given type in the
sample; ++/+, strong staining prevalent, but some weakly stained
cells also visible; ++/2, strong staining present, but negative cells
also present; +/++, majority of cells weakly stained, but some
strong staining present; +/++/2, heterogeneous pattern with a
mixture of strongly positive, weakly stained, and negative cells; +
(1), weak staining overall or (2) strong staining in a small number
of cells; +/2, weak staining in limited areas; and 2/+, weak
staining in single cells.
Quantification of steroid hormones
Tissue samples from intact HFA glands from GWs 8 to 12
(10 male and 10 female, collected from 20 fetuses) and halved
HFA glands from GWs 14 to 19 (9 male and 8 female, collected
from 17 fetuses) were included for the intra-adrenal steroid
analysis by LC-MS/MS measurements. Tissue samples were
weighed (1.7 to 43 mg wet weight) and ground in 1 mL 80%
(v/v) MeOH. The homogenate was transferred to glass tubes
evaporated to almost dryness under an N2 stream. Internal
standard stock solution (5 to 500 ng/mL in 100 mL) was added
to each sample pellet as previously described (22), and 375 mL
1M ammonium acetate buffer (pH, 5.5) was subsequently
added. Next, 2 mLHeptan/Ethylacetat 3:2 (v/v) was added, and
samples were transferred to Eppendorf tubes. Samples were
then shaken for 15 minutes followed by 10 minutes of cen-
trifugation at 2000g (4°C). Each tube was transferred to a dry
ice bath (dry ice pills in ethanol, 99%) for a few minutes to
freeze the aqueous phase, followed by decantation of the or-
ganic phase to a new glass tube. The organic phase was
evaporated to dryness under a stream of N2, and finally, the
steroids were resolved in an appropriate amount of 50% (v/v)
MeOH (tissue GWs 8 to 12: 100 mL; tissue GWs 14 to 19:
Table 1. Primers Used for RT-PCR and Quantitative PCR
Gene HGNC ID Forward Primer Reverse Primer Application Size (bp)
StAR 11359 CACCCCTAGCACGTGGATTA CTTGGTTGCTAAGGATGCCC 152
CYP11A1 2590 ATAAACCGACTCCACGTTGC ACAATGGCTGGCTAAACCTG 134
CYP17A1 2593 GAGTTTGCTGTGGACAAGGG CGCTGGATTCAAGAAACGCT 117
3b-HSD2 5218 CAGGCTCTTTTCAGGAATGG CTTGGACAAGGCCTTCAGAC 117
CYP21A2 2600 GAGTTCTGTGAGCGCATGAG GAATCACGTCCACAATTTGGAT 205
CYP11B1/2 2591/2 CTTCCACTACACCATAGAAGCCAGC CCTCAAAGTGCTCCTTCCACAC 200
ARK1C3 386 GGAGGCCATGGAGAAGTGTAAGGA CCAGAGCACTATAGGCAACCAGAAC 215
SULT2A1 11458 ACAGGACACAGGAAGAACCATAGAG CTTCAGCTTGGGCCACTGTGAA 230
MC2R 6930 ACATGGGCTATCTCAAGCCAC TCCAGATGACCGTAAGCACCA 204
RPS20 10405 AACAAGCCGCAACGTAAAATC ACGATCCCACGTCTTAGAACC 166
SRY 11311 GAATATTCCCGCTCTCCGGA GCTGGTGCTCCATTCTTGAG 470
All primers are shown in 50 to 30 direction.
Abbreviations: ARK1C3, aldo-keto reductase family 1 member C3; HGNC, HUGO Gene Nomenclature Committee.
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200 mL) for LC-MS/MS analysis as previously described (22).
All samples were measured in one single batch, which included
standards for calibration curves, unknown samples, and two
blanks and for method control; three unspiked human serum
pool samples and three serum pool samples spiked with low and
high levels, respectively.
Statistical analysis
Quantitative PCR and LC-MS/MS data were statistically
analyzed for age- and sex-specific differences. Age differences
were tested by the nonparametric Mann-Whitney U test in
which the HFA age groups GWs 10 to 12, GWs 14 to 16, and
GWs 17 to 19 were compared with male GWs 8 to 9. Sex
differences were also tested by the nonparametric Mann-
Whitney U test within each age group. P , 0.05 was consid-
ered statistically significant.
Results
Gene expression patterns of adrenal
steroidogenic enzymes
The selected steroidogenic enzymes were expressed in
all investigated HFA glands at the transcriptional level.
Gene expression patterns were investigated separately in
male and female samples, which were divided into four
age groups: GWs 8 to 9, GWs 10 to 12, GWs 14 to 16,
and GWs 17 to 19. Expression levels were calculated as a
ratio of levels relative to male GWs 8 to 9 (reference value
set to 1). No sex differences were observed in the tran-
scription levels of the examined steroidogenic enzymes or
in the transcription levels of the ACTH receptor,MC2R,
throughout the investigated developmental period
(Fig. 1). During the second trimester, the expression level
of StAR, CYP11A1, CYP17A1, SULT2A1, and MC2R
increased approximately 10-fold, whereas the expression
level of CYP21A2 and CYP11B1/2 increased even fur-
ther, by.50-fold and.20-fold, respectively (Fig. 1e and
1f). Only two of the investigated steroidogenic enzymes
were constitutively expressed throughout the first and
second trimesters, namely 3b-HSD2 and aldo-keto re-
ductase family 1 member C3 (ARK1C3; also known as
17bHSD3) (Fig. 1d and 1g). In addition, the absolute
gene expression levels of 3b-HSD2 and ARK1C3 were
lower than those of the remaining steroidogenic enzymes
(Fig. 1j).
Distribution of steroidogenic enzymes in the
HFA cortex
The morphology of fixed adrenal samples included
in the study was thoroughly examined. All samples
appeared morphologically normal, containing distinct
zones in accordance with the gestational age of the de-
veloping HFA gland (Fig. 2). Sections were stained with
hematoxylin and eosin as well as Mayer hematoxylin.
The DZ consisted of small cells, whereas FZ cells were
larger, with a high content of cytoplasm (Fig. 2c). As
expected, the TZ was detected in second-trimester
samples and consisted of a mixture of small distinct
DZ cells and larger distinct FZ cells (Fig. 2d), as previous
described (1).
The expression profiles of steroidogenic proteins were
analyzed using IHC on fixed adrenal samples. No dif-
ferences between male and female samples were observed
regarding the level of expression and the cell type‒spe-
cific enzyme localization. Therefore, only male samples
are shown for the age groups GWs 8 to 9, GWs 10 to 12,
GWs 14 to 16, andGWs 17 to 19 in Fig. 3. Adrenal zone‒
specific protein expression, localization, and level of
expression were evaluated according to a predefined
scale and are summarized in Table 3.
Most of the investigated steroidogenic enzymes were
abundantly expressed in the FZ throughout development
of both the first and second trimesters (Fig. 3). More
specifically, CYP11A1, CYP21A2, and SULT2A1 were
abundantly expressed in the cytoplasm of first-trimester
FZ cells and weakly expressed in a limited number of DZ
cells toward the late first trimester and throughout the
second trimester. CYP17A1 showed a similar expres-
sion and localization pattern, although CYP17A1 was
expressed specifically in the FZ except for a few strongly
positive cells scattered within the DZ in both first- and
second-trimester samples. During the second trimester,
protein expression of CYP17A1 increased around the TZ
as it decreased in the cells of the inner FZ. In contrast,
Table 2. Antibodies, Dilutions, and Retrieval Buffers Used
Antibody Dilution Retrieval Buffer Species Supplier Number
CYP11A1 1:10,000 TEG Rabbit Sigma HPA016436
CYP17A1 1:1500 CIT Rabbit Abcam Ab134910
3b-HSD1/2 1:6000 TEG Rabbit Gift from Ian Mason —
CYP21A2 1:6000 TEG Goat Santa Cruz Biotechnology Sc-48466
CYP11B1 1:1000 TEG Mouse Santa Cruz Biotechnology Sc-374096
SULT2A1 1:6000 CIT Rabbit Sigma HPA041487
MC2R 1:800 TEG Rabbit Santa Cruz Biotechnology Sc-13107
Antigen retrieval was conducted by pressure cooking of the sections in indicated retrieval buffer for 30 minutes in a decloaking chamber. TEG buffer:
10 mM Tris, 0.5 mM EGTA, pH 9.0; citrate (CIT) buffer: 10 mM, pH 6.0.
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3b-HSD1/2 was the only observed
steroidogenic enzyme frequently
expressed in a limited number of DZ
cells and in only a very few FZ cells.
During the second trimester, 3b-HSD1/
2 was still abundantly expressed,
though only in a subpopulation of DZ
and FZ cells compared with first-
trimester samples.
Like the steroidogenic enzymes, the
ACTH receptor MC2R was also de-
tected throughout the investigated
period of fetal development. More
specifically, weak cytoplasmic MC2R
expression was detected throughout
the first and second trimesters, but
nuclear MC2R expression was also
occasionally found in the late first
trimester and throughout the second
trimester. Therefore, the MC2R ex-
pression patterns observed in this study
should be interpreted with caution
because the unexpected nuclear ex-
pression (23) is most likely an artifact
of the antibody.
HFA steroid tissue concentrations
The endocrine activity of the HFA
was further evaluated by determi-
nation of the intra-adrenal steroid
concentrations. Thus, steroids were
extracted from adrenal gland tissue
followed by LC-MS/MS determination
of mineralocorticoid, glucocorticoid,
and androgen levels. Samples were
divided according to sex and age (as
described previously). All investigated
mineralocorticoids, glucocorticoids,
and androgen metabolites were de-
tected inHFA tissue fromGWs 8 to 19.
Measured concentrations of the
mineralocorticoid metabolites proges-
terone and corticosterone were, in
general, equivalent, with no significant
difference in relation to either gesta-
tional age or sex. The only exception
was a significant age-related increase in
female corticosterone levels at GWs 17 to
19 compared with male tissue concen-
trations at GWs 8 to 9 (Fig. 4a). The
intra-adrenal levels of the glucocorticoid
17OH-progesterone were unaltered over
the investigated developmental period,
Figure 1. Gene expression level of human fetal adrenal steroidogenic enzymes during the
first and second trimesters. (a‒i) Quantitative reverse transcription polymerase chain reaction
analysis of a range of steroidogenic-associated enzymes and receptors in male and female
human fetal adrenal samples divided into four age groups: GWs 8 to 9, GWs 10 to 12, GWs
14 to 16, and GWs 17 to 19. Expression is relative to the reference gene RPS20. The
expression level is set to 1 in male GWs 8 to 9 samples. In total, 39 adrenal samples were
used. Bars represent mean 6 SEM with individual data points shown as blue triangles and
red circles for male and female samples, respectively; n = 3 to 6. Differences in age
compared with male GWs 8 to 9 are indicated as significantly different: *P , 0.05; **P ,
0.01. (j) Overall human fetal adrenal transcript levels from first- and second-trimester
1806 Melau et al Human Fetal Adrenal Steroidogenesis J Clin Endocrinol Metab, May 2019, 104(5):1802–1812
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with no detectable differences between male and female
samples. In contrast, in 11-deoxycortisol, cortisol and
cortisone, a significant increase in intra-adrenal steroid
concentrations was found at GWs 17 to 19 compared with
male GWs 8 to 9 (Fig. 4b). For 11-deoxycortisol, a signif-
icant increase in intra-adrenal steroid concentrations was
further observed at GWs 10 to 12 and GWs 14 to 16, the
latest only in male samples. The only observed sex-specific
difference was found in intra-adrenal cortisone concentra-
tions, which were significantly higher in female samples at
GWs 8 to 9 than in age-matched males (Fig. 4b). In-
terestingly, cortisol levels were the highest of all measured
intra-adrenal steroid hormones throughout the investigated
developmental period. Hence, cortisol tissue concentrations
were approximately twofold higher than those of 17OH-
progesterone and 11-deoxycortisol and approximately
10-fold higher than that of cortisone (Fig. 4b).
Similar to the trend for the majority of measured steroid
hormones, the adrenal tissue concentration of androgens was
relatively constant throughout GWs 8 to 19, with a signifi-
cant increase in testosterone levels found only in male GWs
14 to 16 samples compared with male GWs 8 to 9 tissue
concentrations (Fig. 4c). The adrenal conversion of andros-
tenedione to testosterone appeared to be limited, as tissue
concentrations of androstenedione were approximately
80-fold higher than concentrations of testosterone (Fig. 4c).
Discussion
This study investigated the adrenal steroidogenic ex-
pression pattern during the first and second trimesters of
human fetal development. HFA glands function as active
endocrine organs from early fetal development, which
was confirmed by this study, demonstrating expression
of all investigated steroidogenic enzymes both at the gene
and the protein levels in all investigated samples from
Figure 2. Human fetal adrenal gland morphology and zonation.
Schematic illustrations of the distinct morphological zonation in (a)
first-trimester human fetal adrenals (GWs 8 to 12) and (b) second-
trimester human fetal adrenals (GWs 14 to 19) viewed as a cross
section of the gland. (c) Hematoxylin and eosin (HE) and Mayer
stainings of a first-trimester human fetal adrenal gland. (d) HE and
Mayer stainings of a second-trimester human fetal adrenal gland.
Scale bar = 100 mm.
Figure 3. Expression of steroidogenic enzymes in first- and second-
trimester human adrenal glands. Immunohistochemical staining of
serial sections for CYP11A1, CYP17A1, 3b-HSD1/2, CYP21A2,
CYP11B1, and SULT2A1 (steroidogenic proteins) as
well as MC2R (ACTH receptor) in male samples are shown. No
differences were observed between male and female samples
within a given gestational group; therefore, only male samples are
shown. Scale bar = 100 mm.
Figure 1. (Continued). samples; n = 39. Data points represent
2DCt values (relative to the housekeeping gene RPS20) of
investigated gene transcript levels in individual adrenal samples
(male and female). Error bars represent mean 6 SD. ARK1C3, aldo-
keto reductase family 1 member C3.
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GWs 8 to 19. The distinct morphological expression
pattern of the investigated enzymes is in accordance with
those from previous studies focusing on either first- or
second-trimester human adrenals (4, 7, 8, 10, 11, 13, 14).
Thus, our data support the prominent hypothesis of
the FZ, and later in development also the TZ, being the
main site of de novo steroid synthesis in the HFA. In-
terestingly, the transcription of steroidogenic genes
appeared to be regulated differently, with unaltered ex-
pression of ARK1C3 and 3b-HSD2 during the in-
vestigated period, whereas the expression of the other
steroidogenic enzymes (StAR, CYP11A1, CYP17A1,
CYP21A2, CYP11B1/2, and SULT2A1) and the ACTH
receptorMC2R was significantly increased in the second
trimester (Fig. 5a). The observed increases in gene ex-
pression levels in the second trimester were not evident at
the protein level, presumably because of the lack of
sensitivity of IHC to detect differences in expression
levels. However, the genes upregulated during the second
trimester were also the steroidogenic enzymes that
showed the most abundant immunostaining in the FZ,
while the low constitutively expressed 3b-HSD1/2 was
detected only in a small subpopulation of cells located
mainly in the DZ. Furthermore, the upregulation in gene
expression for the majority of the investigated ste-
roidogenic enzymes was not reflected in higher tissue
concentrations of steroidogenic hormones, which overall
did not differ between the first and second trimesters
(Fig. 5b). It remains to be examined whether the second-
trimester transcriptional upregulation of steroidogenic
enzymes is reflected in steroid levels secreted by the HFA
to the fetal circulation, which was not possible to de-
termine in this study.
The constitutive expression of 3b-HSD1/2 through-
out the first and second trimesters of human fetal develop-
ment in male and female HFA samples contrasts with the
previously reported transient expression profile (3, 4, 7, 8,
11). Thus, our results demonstrate that 3b-HSD1/2 is highly
expressed in a subpopulation of DZ cells fromGWs 8 to 19,
which is in accordance with recently published data (13).
Although the percentage of 3b-HSD1/2‒positive cells in the
DZ and FZ appeared to decrease during the second tri-
mester, this study reports a small number of 3b-HSD1/2‒
positive FZ cells in second-trimester fetuses up to GW 19. In
general, the small number of 3b-HSD1/2‒positive cells
compared with the abundant expression of the majority of
the adrenal steroidogenic enzymes is consistentwith reported
low 3b-HSD2 transcript levels in this study, as well as in
previous reports (3, 4, 11, 13). The immediate imbalance
between low 3b-HSD1/2 expression and high tissue
concentrations of 3b-HSD2‒catalyzed D4 steroids—
progesterone, 17OH-progesterone, and androstenedione—
was previously suggested to be the result of either circulating
placental progesterone or the transfer of intermediates of the
steroid pathways between the adrenal zones (13). The
demonstration by double immunofluorescence staining in
second-trimester HFAs that CYP11A1 and CYP21A2
colocalize in only a limited number of FZ cells (13) could
support the hypothesis of transport of steroidogenic
intermediates between the adrenal zones. Moreover,
the presence of high levels of intra-adrenal androstenedione
in the second trimester determined in this study favors 3b-
HSD2‒dependent de novo synthesis, as 17OH-progesterone
is a poor substrate for humanCYP17A1 (C17,20 lyase) (24),
indicating that adrenal androstenedione is not likely gener-
ated from placental progesterone.
The HFAs produced androgens throughout the first
and second trimesters in both male and female samples.
The detection of high HFA tissue concentrations of
androstenedione and low levels of testosterone indicate
that this step-in steroidogenesis is tightly regulated. The
low intra-adrenal testosterone levels detected from GWs
Table 3. Analysis of Adrenal Zone-Specific Protein Localization and Level of Expression
DZ FZ C
GW: Enzyme 8–9 10–12 14–16 17–19 8–9 10–12 14–16 17–19 17–19
CYP11A1 + (2) + (2) + (2) +/++/2 ++ ++/+ ++/+ ++/+
CYP17A1 2/+ + (2) + (2) + (2) ++/+ ++/+ ++ (TZ), ++/+ (FZ) ++ (TZ), ++/+ (FZ)
SULT2A1 + (2) + (2) + (2) + (2) ++/+ ++/+ ++/+ ++/+
MC2R + (1) +/++ +/++, +/++/2 (n) + (1), ++/2 (n) +/++ +/++ +/++, 2/+(n) +/++, +/++/2 (n) ++/2 (n)
CYP11B1 +/2 2/+ 2/+ 2/+ +/2 +/2 + (1) + (1)
CYP21A2 2/+ + (2) + (2) + (2) +/++ ++/+ ++/+ ++/+
3b-HSD1/2 ++/2 ++/2 +/++/2 +/++/2 + (2) + (2) + (2) + (2)
n = 6215 adrenals within each gestational group. TZ staining is indicated when the TZ protein expression differed from the FZ expression in the second-
trimester tissue (GWs 14219). Scale: ++, strong staining in all cells of a given type in the sample; ++/+, strong staining prevalent, but some weakly
stained cells also visible; ++/2, strong staining present, but negative cells also present; +/++, majority of cells weakly stained, but some strong staining
present; +/++/2, heterogeneous pattern with a mixture of strongly positive, weakly stained, and negative cells; + (1), weak staining overall or (2) strong
staining in a small number of cells; +/2, weak staining in limited areas; 2/+, weak staining in single cells.
Abbreviations: C, capsule; n, nuclear staining.
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8 to 19 are in accordance with previous studies that have
examined both fetal adrenal tissue concentrations and
secreted levels in organ cultures (3, 4, 13). Furthermore,
the low tissue concentrations of testosterone are in
accordance with the relatively low transcriptional ex-
pression level of ARK1C3, which mediates adrenal de
novo testosterone synthesis. The expression level of
ARK1C3 in first-trimester samples detected in this study
Figure 4. Tissue levels of steroids in first- and second-trimester human adrenals. (a‒c) LC-MS/MS measurements (ng/g, wet tissue) of adrenal steroid
hormones were determined from male and female adrenal tissue extracts. Bars represent mean 6 SEM; individual data points shown as blue triangles and
red circles represent male and female samples, respectively; n = 3 to 5. Differences in age compared with male GWs 8 to 9 are indicated as significantly
different: *P , 0.05. Differences between sexes within the same age group are indicated as significantly different ¤P , 0.05.
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supports previous investigations (3, 4), whereas ARK1C3
expression levels, to our knowledge, have not been in-
vestigated previously in second-trimester HFA tissue.
Consequently, the significant increase in male testosterone
levels at GWs 14 to 16 comparedwith levels inmale GWs 8
to 9 is inconsistent with the observed overall unaltered
Figure 5. Overview of human fetal adrenal steroidogenic development. (a) Schematic overview of adrenal steroidogenesis. Gene transcripts of
enzymes significantly upregulated in the second trimester are shown in green boxes, with unaltered gene transcripts shown in red boxes.
Measured steroid hormones are shown in boldface font. (b) Overview of steroid hormone levels relative to progesterone levels throughout the
investigated developmental period. Data are shown as mean values of fetal adrenal samples (for SEM values, see data in Fig. 4). DHEA,
dehydroepiandrosterone.
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expression level of ARK1C3, suggesting that testosterone
levels are not regulated solely via gene transcription. The
observed peak inmale testosterone aroundGWs 14 to 16 is
not significantly different from levels in the female GWs 14
to 16 age group, and it is likely that adrenal testosterone
production is considerably lower than the contribution
from the fetal testis (25).Moreover, this study reported that
androstenedione is the most abundant D4 adrenal an-
drogen synthesized by the classic steroidogenic pathway
throughout the first and second trimesters in HFA, which
contrasts with a previously reported higher adrenal an-
drogen production during the first trimester (13).
The HFA produces cortisol throughout the first and
second trimesters, indicating continued regulation of the
HPA axis during this entire period. In line with this finding
is the detection of cytoplasmic MC2R expression from
GW 8, which is in accordance with findings of previous
studies (3, 4). However, because of the unexpected ad-
ditional nuclear expression of MC2R observed in this
study, these results should be interpreted with caution;
MC2R is known to be expressed in the cytoplasm (at the
endoplasmic reticulum) until it is translocated withMRAP
to the plasmamembrane to mediate ACTH signaling (23).
The abundant HFA tissue concentrations of cortisol de-
tected in this study further support the recent hypothesis
that cortisol-mediated negative feedback of the HPA axis
is not restricted to the first trimester but extends through
the second trimester (13). Detection of intra-adrenal
cortisol in the second trimester is consistent with the
observed expression of 3b-HSD1/2 and is in accordance
with a previous study that detected cortisol in HFA tissue
from the second trimester (13), although the cortisol
concentrations measured in the current study are ap-
proximately 10-fold higher than the concentrations pre-
viously reported. During GWs 8 to 14, cortisol-mediated
negative feedback on the HPA axis is thought to be crucial
because this period is thewindow of development in which
the sex-specific differentiation of gonads and external
genitalia occurs (15, 16). Hence, dysregulated adrenal
steroidogenesis, which results in an imbalance with an
excess of adrenal androgens and reduced cortisol in this
time window, can cause virilization of female genitalia in
fetuses with CAH (17). Because adrenal androgens can
be converted to estrogens by the placental aromatase
(CYP19A1) later in pregnancy, the adrenal secretion of
androgens during the second trimester is thought to have
less effect on genital differentiation (15, 16). However, the
observed abundant concentration of cortisol throughout
the first and second trimesters raises new questions about
whether alterations in cortisol production can still affect
virilization of fetuses with CAH during the second tri-
mester or may possibly influence other events during
human fetal development.
This study provides detailed characterizations of both
male and female adrenal endocrine functions during the
first and second trimesters of human fetal development. It is
evident from the gene and protein expression patterns of
steroidogenic enzymes, as well as the steroid measurements
in tissues, that the HFA functions as an active steroidogenic
organ from early development by producing high levels of
mineralocorticoids, glucocorticoids, and androgens. Even
from GW 8, we report a distinct expression pattern for the
investigated adrenal steroidogenic enzymes, with a major
increase in gene expression in second-trimester samples for
the majority of steroidogenic enzymes, with the exception
of the unaltered expression of 3b-HSD2 andARK1C3. On
the basis of the intra-adrenal steroid hormone concentra-
tions, we found that androstenedione is the most abundant
D4 adrenal androgen synthesized via the classic steroido-
genic pathway throughout the first and second trimesters.
In addition, this study confirms that cortisol is produced
throughout the first and second trimesters, suggesting
continued regulation of the HPA axis during this entire
period.
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